Inventor · disambiguated record
Michele A. Cleary
Also filed as: CLEARY MICHELE · CLEARY MICHELE A
4 granted patents·8 pending applications·8 citations·filing 2000–2025
66Inventor score
Files withBRISTOL MYERS SQUIBB CO3FRIEND STEPHEN H2CLEARY MICHELE A1GENERATION BIOTECH LLC1IVANOVSKA IRENA1
Top patents by PatentIndex Score
12 records- 0179US8378088B2Compositions comprising MIR34 therapeutic agents for treating cancerMERCK SHARP & DOHME·Filed 2008·Granted Feb 19, 2013·3 cites·18 claims
- 0278US8399248B2Methods of using MIR34 as a biomarker for TP53 functional statusCLEARY MICHELE A·Filed 2008·Granted Mar 19, 2013·5 cites·14 claims
- 0376US2025382368A1Methods of treating a non-small cell lung cancer using an anti-pd-1 antibodyBRISTOL MYERS SQUIBB CO·Filed 2025·Application pending·0 cites
- 0470US2022315657A1Anti-pd-1 antibody for use in a method of treating a tumorBRISTOL MYERS SQUIBB CO·Filed 2022·Application pending·0 cites
- 0557US2010113287A1Methods for assessing the representation of nucleic acid molecules in a nucleic acid libraryROSETTA INPHARMATICS LLC·Filed 2009·Application pending·0 cites
- 0656US8133670B2Method for making populations of defined nucleic acid moleculesFRIEND STEPHEN H·Filed 2004·Granted Mar 13, 2012·0 cites·26 claims
- 0756US2020325226A1Anti-pd-1 antibody for use in a method of treating a tumorBRISTOL MYERS SQUIBB CO·Filed 2017·Application pending·0 cites
- 0851US2008090733A1Method for selectively isolating a nucleic acidGENERATION BIOTECH LLC·Filed 2007·Application pending·0 cites
- 0949US2009136957A1Methods and compositions for regulating cell cycle progression via the miR-106B familyIVANOVSKA IRENA·Filed 2008·Application pending·0 cites
- 1048US2001031467A1Method for selectively isolating a nucleic acidFiled 2000·Application pending·0 cites
- 1143US2005181385A1Synthetic lethal screen using RNA interferenceFiled 2004·Application pending·0 cites
- 1229US8753811B2Method for making populations of defined nucleic acid moleculesFRIEND STEPHEN H·Filed 2012·Granted Jun 17, 2014·0 cites·24 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →